Insulin resistance and hyperinsulinemia in non-diabetic non-obese benign prostatic hyperplasia patients

Nejris Helal, Nehad; Mohsin Abdul-Aziz, Mohammed

	Insulin resistance and hyperinsulinemia in non-diabetic non-obese benign prostatic hyperplasia patients
Medical Journal of Tikrit
Article 1, Volume 2, Issue 142, 2016, Pages 138-142
Authors
Nehad Nejris Helal; Mohammed Mohsin Abdul-Aziz
Abstract
Benign Prostatic Hyperplasia (PBH) is the most common benign tumor in men, and its incidence is age related. Despite intense research efforts in the past five decades to elucidate the underlying etiology of prostatic growth in older men, cause and effect relationships have not been established. Insulin is a growth-stimulating hormone. Previous studies have reported the association between hyperinsulinemia and BPH in patients with metabolic disorders like diabetes. To assess insulin level and insulin resistance in non-diabetic non-obese BPH cases and correlated them with prostate size. 35 symptomatic BPH cases and 30 controls were included in this study. Fasting serum insulin concentrations were measured by enzyme-linked immunosorbent assay (ELISA). Insulin resistance was assessed by homeostatic model assessment (HOMA). Fasting glucose was quantified by glucose oxidase method. PSA was calculated by ELISA. Prostatic size was measured by ultrasonography. Fasting serum insulin and HOMA were significantly higher in BPH cases as compared to controls (P value < 0.01 and < 0.001 respectively). Hyperinsulinemia and accompanying insulin resistance were found to be risk factors of increased prostatic size, (P value < 0.00
Keywords
Insulin resistance and hyperinsulinemia in non; diabetic non; obese benign prostatic hyperplasia patients

Statistics Article View: 43 PDF Download: 1